Since 28th to 31st of October Artyom Yelchev, an IKBFU postgraduate has participated in International Scientific Conference “Marine Research and Education: MARESEDU - 2019”, that was held at the Institute of Oceanology in Moscow.
The immunity diagnostics system, developed by Russian scientists can help solving the demographic problem.
Andrey Prodeus, Research Professor at the IKBFU Medical School, Chief Pediatrician at Speranskiy Children’s Clinical Hospital №9 has taken part in the research which results were published in Frontiers in physiology scientific journal.
“Coherent optics for MEGA-science class plants” research center scientists – Ksenia Chichay and Sergey Shevirtalov have participated in SpinS workshop in Mulheim (Germany) on 2-4th of October and XSMM workshop in Grenoble (France) on 7-9th of October 2019.
IKBFU scientific group for the development of human-machine interaction technologies won first place in the international competitions of assistive technologies "Neurotlon" in the BCI –Brain-Computer Interface discipline, with the goal to control an avatar in a specially designed computer game.
On October 28-29, prof. Inna Lavrik, professor at the University of Otto von Guericke of the Faculty of Medicine, Center for Dynamic Systems (Magdeburg, Germany) visited the university. She presented lectures and conducted a seminar on the topics: “Research on translational inflammation”, “CD95 signaling as a pro-apoptotic death receptor”, and “Death receptor network targeting using rationally designed chemical probes”.
According to the World Health Organization, tuberculosis is one of the 10 leading causes of death in the world. Tuberculosis caused by antibiotic-resistant strains of the bacterium Mycobacterium tuberculosis is especially dangerous.
On the 31st of October 2019, the IKBFU Acting Rector Alexander Fedorov has participated in President of Russia Vladimir Putin’s press-conference to the public of the Kaliningrad region. Alexander Fedorov added that the center will be a platform for scientific research, as well as development, testing and application of “people-oriented” technologies and products aimed at improving standards of living and increasing live expectancy.